Short Information | Inhibikase Therapeutics Inc. (NASDAQ:IKT)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 77,177 |
Total Actual Volume | 505,197 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 3,859 |
Average Short Percentage | 17.12% |
Is there a IKT Short Squeeze or Breakout about to happen?
See the IKT Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $1.2 | $1.16 | $1.4 | $1.14 | 40,441 | 716 | 1.77% |
07-03-2024 | $1.15 | $1.1505 | $1.255 | $1.145 | 68,062 | 7,989 | 11.74% |
07-02-2024 | $1.3099 | $1.21 | $1.3099 | $1.2 | 14,775 | 3,818 | 25.84% |
07-01-2024 | $1.24 | $1.24 | $1.27 | $1.13 | 44,339 | 12,960 | 29.23% |
06-28-2024 | $1.385 | $1.21 | $1.45 | $1.17 | 62,341 | 7,466 | 11.98% |
06-27-2024 | $1.4 | $1.37 | $1.52 | $1.36 | 15,672 | 3,000 | 19.14% |
06-26-2024 | $1.39 | $1.41 | $1.43 | $1.26 | 24,467 | 2,078 | 8.49% |
06-25-2024 | $1.38 | $1.3855 | $1.4 | $1.31 | 9,010 | 2,150 | 23.86% |
06-24-2024 | $1.43 | $1.33 | $1.44 | $1.31 | 22,716 | 2,339 | 10.3% |
06-21-2024 | $1.41 | $1.4 | $1.5 | $1.35 | 30,123 | 1,472 | 4.89% |
06-20-2024 | $1.49 | $1.43 | $1.49 | $1.4095 | 17,613 | 7,799 | 44.28% |
06-18-2024 | $1.6366 | $1.49 | $1.64 | $1.47 | 12,774 | 1,350 | 10.57% |
06-17-2024 | $1.42 | $1.59 | $1.59 | $1.42 | 24,467 | 3,091 | 12.63% |
06-14-2024 | $1.5 | $1.41 | $1.515 | $1.392 | 19,430 | 3,838 | 19.75% |
06-13-2024 | $1.57 | $1.53 | $1.57 | $1.52 | 8,052 | 1,455 | 18.07% |
06-12-2024 | $1.64 | $1.58 | $1.7103 | $1.54 | 23,856 | 4,842 | 20.3% |
06-11-2024 | $1.56 | $1.595 | $1.6651 | $1.53 | 12,464 | 2,703 | 21.69% |
06-10-2024 | $1.61 | $1.63 | $1.691 | $1.53 | 14,828 | 3,426 | 23.1% |
06-07-2024 | $1.635 | $1.69 | $1.695 | $1.61 | 13,641 | 1,942 | 14.24% |
06-06-2024 | $1.78 | $1.66 | $1.8299 | $1.5 | 26,126 | 2,743 | 10.5% |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...